About Acies Pharmaceutical
Acies Pharmaceutical is a Healthcare company based in Dehradun (India). Manufacturing and exporting of pharmaceutical, nutraceutical, and ayurvedic products in India. Its Indian entity Acies Pharmaceutical Private Limited reported revenue of ₹37.03 Cr. Acies Pharmaceutical offers products and services including Tablets and Capsules and Liquid Orals. Its focus areas include Pharmaceuticals, Drug Manufacturing, Formulations and Nutraceuticals.
Company details
Acies Pharmaceutical is recognized as a manufacturer and exporter of pharmaceutical, nutraceutical, and ayurvedic products, having been established in 2016. Its facilities are equipped with state-of-the-art technology and are WHO-GMP approved, ensuring products meet international standards. Quality surveys are conducted for each item to maintain purity and effectiveness, while exports are directed to global and domestic markets. The company is noted for its ethical policies and timely delivery, with a focus on enhancing human life through quality medicines. Operations are managed from Uttarakhand, India, involving formulations like tablets, capsules, syrups, and injections.
- Headquarters Dehradun, India
- SectorsHealthcare
- Phone•••• ••••
- Social Instagram
- Legal Name Acies Pharmaceutical Pvt Ltd
- Date of Incorporation 19 Apr, 2019
- Jurisdiction Dehradun, Uttarakhand, India
- Annual Revenue₹37.03 Cr
FY 2025 · +68% YoY
- Net Profit₹2.57 Cr
FY 2025 · 7% margin
- EBITDA₹3.86 Cr
FY 2025 · 10% margin
Associated legal entities of Acies Pharmaceutical
Acies Pharmaceutical operates through Acies Pharmaceutical Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Acies Pharmaceutical Private Limited CIN U74999UR2019PTC009735 | Active | 19 Apr 2019 | Dehradun, Uttarakhand | ₹37.0 Cr | 2 | View details |
Products & Services of Acies Pharmaceutical
Acies Pharmaceutical offers a comprehensive portfolio of products and services, including Tablets and Capsules and Liquid Orals.
Tablets and capsules are formulated for treating various diseases using high-grade materials
Liquid orals such as syrups are processed for medical applications with a focus on effectiveness
Board of directors of Acies Pharmaceutical Private Limited (Acies Pharmaceutical)
Acies Pharmaceutical Private Limited is the primary company behind Acies Pharmaceutical. The board of Acies Pharmaceutical Private Limited currently have 2 directors; the longest-serving is Bhasker Dabral, appointed in 2019.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Bhasker Dabral DIN 08426742 | Director | 19 Apr 2019 | 7 yrs 6 mo | Acies Pharmaceutical Private Limited |
| Sujata Dabral DIN 08426753 | Director | 19 Apr 2019 | 7 yrs 6 mo | Acies Pharmaceutical Private Limited |
Financials of Acies Pharmaceutical
Figures of Acies Pharmaceutical Private Limited, the primary company behind Acies Pharmaceutical, for FY 2025. Revenue was ₹37.03 Cr (+68% year on year). Net profit was ₹2.57 Cr (7% margin). EBITDA was ₹3.86 Cr (10% margin). Revenue has grown at a compounded annual rate of +36% over three years and +153% over five years.
- ₹37.03 CrRevenue · FY 2025 · +68% YoY
- ₹2.57 CrNet profit · 7% margin
- ₹3.86 CrEBITDA · 10% margin
- ₹1 LakhPaid-up capital
- +36%Revenue CAGR, 3 years
- +153%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Acies Pharmaceutical Private Limited are on its company page.
Detailed financial statements for Acies Pharmaceutical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Acies Pharmaceutical
Acies Pharmaceutical is headquartered in Dehradun, India. It is registered at Dehradun, Uttarakhand, India.
The primary company behind Acies Pharmaceutical, Acies Pharmaceutical Private Limited, reported revenue of ₹37.03 Cr for FY 2025, up 68% year on year.
Acies Pharmaceutical is recognized as a manufacturer and exporter of pharmaceutical, nutraceutical, and ayurvedic products, having been established in 2016. Its facilities are equipped with state-of-the-art technology and are WHO-GMP approved, ensuring products meet international standards. Quality surveys are conducted for each item to maintain purity and effectiveness, while exports are directed to global and domestic markets. The company is noted for its ethical policies and timely delivery, with a focus on enhancing human life through quality medicines. Operations are managed from Uttarakhand, India, involving formulations like tablets, capsules, syrups, and injections.
Acies Pharmaceutical offers Tablets and Capsules and Liquid Orals.
Acies Pharmaceutical operates through Acies Pharmaceutical Private Limited.
The legal entities of Acies Pharmaceutical currently have 2 directors, including Bhasker Dabral, Sujata Dabral.